Efficacy and Safety of Off-Label Use of Fondaparinux in the Management of Heparin-Induced Thrombocytopenia With Thrombosis in an Elderly Woman

被引：2
|
作者：
Leporini, Christian [1 ,2 ]
Rende, Antonio [3 ]
Sorrentino, Alfonso [4 ]
Rizzica, Elvira [5 ]
Russo, Emilio [1 ,2 ]
Gallelli, Luca [1 ,2 ]
De Sarro, Giovambattista [1 ,2 ]
机构：
[1] AO Mater Domini, Ctr Reg Informaz Farmaco, Catanzaro, Italy
[2] Univ Catanzaro, Sch Med, Dept Hlth Sci, Catanzaro, Italy
[3] San Francesco di Paola Hosp, Transfus Med Unit, Rome, Italy
[4] Tor Vergata Univ, Sch Med & Surg, Rome, Italy
[5] San Francesco di Paola Hosp, Farm Osped, Rome, Italy
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2013年 / 53卷 / 09期
关键词：
HIT; HITT; nadroparin; 4Ts score; Fondaparinux; ADVERSE DRUG-REACTIONS; RETROSPECTIVE ANALYSIS; PATIENT; ANTIBODIES; ULCERATION; HIT;
D O I：
10.1002/jcph.124
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：999 / 1002
页数：4
相关论文
共 50 条
  • [21] Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - findings from the GerHIT multi-centre registry study
    Schindewolf, Marc
    Steindl, Julia
    Beyer-Westendorf, Jan
    Schellong, Sebastian
    Dohmen, Pascal Maria
    Brachmann, Johannes
    Madlener, Katharina
    Poetzsch, Bernd
    Klamroth, Robert
    Hankowitz, Johannes
    Banik, Norbert
    Eberle, Sonja
    Kropff, Stefan
    Mueller, Markus Michael
    Lindhoff-Last, Edelgard
    THROMBOSIS RESEARCH, 2014, 134 (01) : 29 - 35
  • [22] Heparin-induced thrombocytopenia in an obese pregnant woman with venous thrombosis
    Kozak, Matija
    Vizintin Cuderman, Tjasa
    Bozic-Mijovski, Mojca
    Lucovnik, Miha
    Tratar, Gregor
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (07) : 3380 - 3381
  • [23] Heparin/argatrobanHeparin-induced thrombocytopenia and off-label use: case report
    Reactions Weekly, 2021, 1883 (1) : 190 - 190
  • [24] Fondaparinux-sodium/heparinHeparin-induced thrombocytopenia and off-label use: case report
    Reactions Weekly, 2020, 1826 (1) : 136 - 136
  • [25] Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia
    Al-Eidan, Fahad A. S.
    Alrawkan, Saud
    Alshammary, Huda
    Crowther, Mark A.
    ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2055 - 2059
  • [26] Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - final results from the GerHIT multi-centre registry study
    Schindewolf, M.
    Steindl, J.
    Beyer-Westendorf, J.
    Schellong, S.
    Dohmen, P. M.
    Brachmann, J.
    Madlener, K.
    Poetzsch, B.
    Klamroth, R.
    Lindhoff-Last, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 935 - 935
  • [27] Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia
    Fahad A. S. Al-Eidan
    Saud Alrawkan
    Huda Alshammary
    Mark A. Crowther
    Annals of Hematology, 2018, 97 : 2055 - 2059
  • [28] Can heparin-induced thrombocytopenia be associated with fondaparinux use? Reply to a rebuttal
    Warkentin, T. E.
    Lim, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (07) : 1243 - 1246
  • [29] Recognition, diagnosis, and management of heparin-induced thrombocytopenia and thrombosis
    Smoot, EC
    Marx, A
    Weiman, D
    Deitcher, SR
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 103 (02) : 559 - 565
  • [30] Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis
    Alving, BM
    Krishnamurti, C
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (06): : 569 - 574
12345